Background Crohn's disease (CD)–associated dysbiosis could predispose patients to
relapse. Gut microbiota composition of patients from the prospective cohort study designed …

The fecal microbiota is a rich source of biomarkers that have previously been shown to be
predictive of numerous disease states. Less well studied is the effect of immunomodulatory …

Clostridium difficile infection (CDI) is a common complication in inflammatory bowel disease
(IBD) and has been associated with poor IBD outcome. Intestinal microbiota composition in …

Background Crohn's disease [CD] is known to be associated with gut microbial dysbiosis.
Infliximab [IFX] is increasingly used to treat paediatric CD; however, it is not clear how the …

Methods Fecal samples from 70 ulcerative colitis (UC) patients, 39 Crohn's disease (CD)
patients, and 100 healthy control individuals (HC) were collected. The fecal samples were …

Bacteria abundance alternation in the feces or mucosa of Crohn's disease (CD) patients has
long been applied to identify potential biomarkers for this disease, while the taxa occurrence …

We previously discovered that gut microbiota can serve as universal microbial biomarkers
for diagnosis, disease activity assessment, and predicting the response to infliximab …

Background and aim: A role for the intestinal microbial community (microbiota) in the onset
and chronicity of Crohn's disease (CD) is strongly suspected. However, investigation of such …

Abstract Background and Aims The pathogenesis of Crohn's disease [CD] is still unclear.
Disorders in the mucosal immunoregulation and its crosstalk with the microbiota may …

Background In recent years, the gut microbiota has been found to provide an important link
to the development of inflammatory bowel diseases (IBD) like ulcerative colitis (UC) …